Close Menu

In a paper published online in advance in Nature this week, the Cold Spring Harbor Laboratory's Michael Wigler et al. report their use of whole-genome amplification and next-gen sequencing on flow-sorted nuclei isolated from polygenomic tumor cells to determine that, "in contrast to gradual models of tumor progression, our data indicate that tumors grow by punctuated clonal expansions with few persistent intermediates."

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Two COVID-19 vaccine developers have released their trial protocols to build public trust, the New York Times reports.

A new analysis finds the rapid COVID-19 test from DnaNudge to be highly accurate, Reuters reports.

In Science this week: global citizens' assembly on genome-editing technologies proposed, epigenetic markers predict metformin response, and more.

According to the Verge, many US states are not including positive results from rapid COVID-19 testing in their case numbers.